Infections involving the aorta are particularly complex, posing unique diagnostic and therapeutic challenges. Aortic infections (AIs) are associated with considerable morbidity and mortality and incur significant healthcare costs. This narrative review examines the current literature and offers guidance on primary and post-operative AIs.
Methods:
We conducted a search using electronic databases (PubMed, Medline, Scopus, and Cochrane) with a Boolean approach using selected keywords of aorta and infection, aortitis, aortic graft infection, infected aortic aneurysm, and mycotic aneurysm.
Results:
AIs are among the most feared complications in vascular surgery. Gram-positive bacteria, such as Staphylococcus aureus, are responsible for about 80% of AIs. These microorganisms produce toxins capable of leading to anastomotic disruption. The common use of broad-spectrum antibiotic agents has resulted in an increasing prevalence of multi-drug-resistant organisms, making the management of AIs even more complex. Clinical presentation is often non-specific, ranging from mild symptoms, such as abdominal pain, malaise, and fever, to sepsis and hemorrhagic shock due to anastomotic rupture. Management of patients with an infected aorta includes antimicrobial therapy and surgical source control, which may include washout and aneurysm repair if a primary aortic infection or graft removal if a post-operative infection. Collaboration with intensive care unit and ID consultation improved long-term outcomes.
Conclusions:
AIs are among the most complicated and challenging surgical problems and are potentially life-threatening and require a multi-disciplinary approach to reduce its prevalence and improve clinical outcomes.
HoranTC, AndrusM, DudeckMA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control, 2008; 36(5):309–332.
2.
BanKA, MineiJP, LarongaC, et al.American college of surgeons and surgical infection society: Surgical site infection guidelines, 2016 update. J Am Coll Surg, 2017; 224(1):59–74.
3.
GeJ, WengC, ZhaoJ, et al.Management and clinical outcome of aortic graft infections: A single-center retrospective study. J Clin Med, 2022; 11(21):6588.
4.
FrankelWC, GreenSY, AmarasekaraHS, et al.Early and late outcomes of surgical repair of mycotic aortic aneurysms: A 30-year experience. J Thorac Cardiovasc Surg, 2024; 167(2):578–587.
5.
SchanzerA, NahmiasJ, KorendaK, et al.An increasing demand for integrated vascular residency training far outweighs the limited supply of positions. J Vasc Surg, 2009; 50(6):1513–1518; discussion 8.
BuckmasterMJ, CurciJA, MurrayPR, et al.Source of elastin-degrading enzymes in mycotic aortic aneurysms: Bacteria or host inflammatory response? Cardiovasc Surg, 1999; 7(1):16–26.
11.
CoxK, SundaramRD, PopescuM, et al.A review on the deeper understanding of inflammation and infection of the thoracic aorta. Vascular, 2023; 31(2):257–265.
12.
TöpelI, ZorgerN, SteinbauerM. Inflammatory diseases of the aorta: Part 2: Infectious aortitis. Gefasschirurgie, 2016; 21(Suppl 2):87–93.
13.
ShiY, GuoW, HuW, et al.Aortic involvement in disseminated tuberculosis - Challenges beyond the diagnosis. Infect Drug Resist, 2022; 15:2633–2638.
14.
WuS, ShenY, ZhangS, et al.Salmonella interacts with autophagy to offense or defense. Front Microbiol, 2020; 11:721.
15.
MeadeRH3rd, MoranJM. Salmonella arteritis–preoperative diagnosis and cure of salmonella typhimurium aortic aneurysm. N Engl J Med, 1969; 281(6):310–312.
16.
Orellana DavilaB, MancusiC, CoscarellaC, et al.Urgent or emergent endovascular aortic repair of infective aortitis. J Clin Med, 2024; 13(16):4669.
17.
WanhainenA, Van HerzeeleI, Bastos GoncalvesF, et al.; Document Reviewers. Editor’s choice—European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal Aorto-Iliac artery aneurysms. Eur J Vasc Endovasc Surg, 2024; 67(2):192–331.
18.
JutidamrongphanW, KritprachaB, SöreliusK, et al.Features of infective native aortic aneurysms on computed tomography. Insights Imaging, 2022; 13(1):2.
19.
BoisJP, AnandV, AnavekarNS. Detection of inflammatory aortopathies using multimodality imaging. Circ Cardiovasc Imaging, 2019; 12(7):e008471.
20.
MA3RS Study Investigators. Aortic wall inflammation predicts abdominal aortic aneurysm expansion, rupture, and need for surgical repair. Circulation, 2017; 136(9):787–797.
21.
MurakamiM, MorikageN, SamuraM, et al.Fluorine-18-fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis of infected aortic aneurysms. Ann Vasc Surg, 2014; 28(3):575–578.
HakimS, DavilaF, AminM, et al.Infectious aortitis: A life-threatening endovascular complication of nontyphoidal salmonella bacteremia. Case Rep Med, 2018; 2018:6845617.
24.
AllenN, AdamM, O’ReganG, et al.Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation. BMC Infect Dis, 2021; 21(1):670.
25.
ErbS, SidlerJA, ElziL, et al.Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: A retrospective study of treatment outcomes. PLoS One, 2014; 9(11):e112947.
26.
CampolmiM, PugesM, SöreliusK, et al.Management of complex aortic endograft infection by a multidisciplinary team. Ann Vasc Surg, 2025; 120:361–372.
27.
LeeCH, HsiehHC, KoPJ, et al.Treatment of infected abdominal aortic aneurysm caused by salmonella. Ann Vasc Surg, 2014; 28(1):217–226.
28.
HuangYK, ChenCL, LuMS, et al.Clinical, microbiologic, and outcome analysis of mycotic aortic aneurysm: The role of endovascular repair. Surg Infect (Larchmt), 2014; 15(3):290–298.
29.
AokiC, FukudaW, KondoN, et al.Surgical management of mycotic aortic aneurysms. Ann Vasc Dis, 2017; 10(1):29–35.
30.
ChakféN, DienerH, LejayA, et al.Editor’s choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections. Eur J Vasc Endovasc Surg, 2020; 59(3):339–384.
31.
TabieiA, CifuentesS, GlasgowAE, et al.Cryopreserved arterial allografts vs rifampin-soaked Dacron for the treatment of infected aortic and iliac grafts. J Vasc Surg, 2023; 78(4):1064–1073.e1.
32.
GirshfeldSJ, MottaJC, De GrandisEC, et al.Contemporary experience of the neo-aortoiliac system (NAIS) procedure: A case series with review of the literature. Ann Vasc Surg, 2024; 109:358–369.
33.
BarilDT, CarroccioA, PalchikE, et al.Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg, 2006; 20(4):464–471.
34.
FillmoreAJ, ValentineRJ. Surgical mortality in patients with infected aortic aneurysms. J Am Coll Surg, 2003; 196(3):435–441.
35.
LinCH, HsuRB. Primary infected aortic aneurysm: Clinical presentation, pathogen, and outcome. Acta Cardiol Sin, 2014; 30(6):514–521.
36.
OderichGS, PannetonJM, BowerTC, et al.Infected aortic aneurysms: Aggressive presentation, complicated early outcome, but durable results. J Vasc Surg, 2001; 34(5):900–908.
37.
ChinsakchaiK, WiangphoemN, WongwanitC, et al.Early and late outcomes of endovascular aneurysm repair for infected abdominal aortic and/or iliac aneurysms. Ann Vasc Surg, 2022; 87:411–421.
38.
SuwanruangsriV, BokerdS, ChinchalongpornW, et al.Midterm outcomes of endovascular treatment for infected aortic aneurysms: Single center experience. Vascular, 2024; 32(2):303–309.
39.
CaraduC, JolivetB, PugesM, et al.Reconstruction of primary and secondary aortic infections with an antimicrobial graft. J Vasc Surg, 2023; 77(4):1226–1237.e10.
40.
VoorheesABJr, JaretzkiA3rd, BlakemoreAH. The use of tubes constructed from vinyon “N” cloth in bridging arterial defects. Ann Surg, 1952; 135(3):332–336.
41.
WilsonWR, BowerTC, CreagerMA, et al.; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Peripheral Vascular Disease; and Stroke Council. Vascular graft infections, mycotic aneurysms, and endovascular infections: A scientific statement from the American heart association. Circulation, 2016; 134(20):e412–e460.
42.
VogelTR, SymonsR, FlumDR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg, 2008; 47(2):264–269.
BattM, CamouF, CoffyA, et al.A meta-analysis of outcomes of in-situ reconstruction after total or partial removal of infected abdominal aortic graft. J Cardiovasc Surg (Torino), 2020; 61(2):171–182.
45.
BattM, FeugierP, CamouF, et al.; Research Group for Vascular Graft Infection. A meta-analysis of outcomes after in situ reconstructions for aortic graft infection. Angiology, 2018; 69(5):370–379.
46.
LyonsOT, BaguneidM, BarwickTD, et al.Diagnosis of aortic graft infection: A case definition by the management of aortic graft infection collaboration (MAGIC). Eur J Vasc Endovasc Surg, 2016; 52(6):758–763.
47.
ShukuzawaK, OhkiT, MaedaK, et al.Risk factors and treatment outcomes for stent graft infection after endovascular aortic aneurysm repair. J Vasc Surg, 2019; 70(1):181–192.
48.
PlotkinA, MageeGA, ElsayedRS, et al.Methicillin-resistant Staphylococcus aureus portends a poor prognosis after endovascular repair of mycotic aortic aneurysms and aortic graft infections. J Vasc Surg, 2020; 72(1):276–285.
49.
MastersonLL, KudlatyE, MalhotraL, et al.Bacteriology and treatment of aortic graft infection: A modern perspective. J Vasc Surg, 2015; 62(3):823.
50.
GouveiaEMR, MartinsB, PedroDM, et al.Microbial evolution of vascular graft infections in a tertiary hospital based on positive graft cultures. J Vasc Surg, 2021; 74(1):276–284.e4.
51.
PugesM, CaraduC, SvahnI, et al.An ex vivo study of infections of vascular grafts and endografts with scanning electron microscopy. J Vasc Surg, 2024; 80(2):554–563.e4.
52.
FilipeR, CeiaF, CarvalhoAC, et al.Aortic prosthesis-associated MDR pseudomonas infections as a diagnostic and therapeutic challenge. Infect Dis Rep, 2020; 12(3):46–50.
53.
OmranS, GrögerS, ShafeiB, et al.Outcomes of candida and non-candida aortic graft infection. Vasc Endovascular Surg, 2023; 57(2):97–105.
54.
LauriC, SignoreA, GlaudemansA, et al.Evidence-based guideline of the European association of nuclear medicine (EANM) on imaging infection in vascular grafts. Eur J Nucl Med Mol Imaging, 2022; 49(10):3430–3451.
55.
DibbleEH, YooDC, BairdGL, et al.FDG PET/CT of infection: Should it replace labeled leukocyte scintigraphy of inpatients? AJR Am J Roentgenol, 2019; 213(6):1358–1365.
56.
BourqueJM, Birgersdotter-GreenU, BravoPE, et al.(18)F-FDG PET/CT and radiolabeled leukocyte SPECT/CT imaging for the evaluation of cardiovascular infection in the multimodality context: ASNC Imaging Indications (ASNC I(2)) series expert consensus recommendations from ASNC, AATS, ACC, AHA, ASE, EANM, HRS, IDSA, SCCT, SNMMI, and STS. Heart Rhythm, 2024; 21(5):e1–e29.
57.
LiB, HennesseyH, FentonJ, et al.Presentation and management of delayed aortic endograft infection. BMJ Case Rep, 2023; 16(3):e252924.
58.
JunghansS, RojasSV, SkusaR, et al.Bacteriophages for the treatment of graft infections in cardiovascular medicine. Antibiotics (Basel), 2021; 10(12):1446.
59.
NegutI, BitaB, GrozaA. Polymeric coatings and antimicrobial peptides as efficient systems for treating implantable medical devices associated-infections. Polymers (Basel), 2022; 14(8):1611.
60.
SeegerJM. Management of patients with prosthetic vascular graft infection. Am Surg, 2000; 66(2):166–177.
61.
TsilimparisN, GouveiaEMR, TenorioER, et al.Multicenter study on physician-modified endografts for thoracoabdominal and complex abdominal aortic aneurysm repair. Circulation, 2024; 150(17):1327–1342.
62.
BockeriaLA, SvanidzeO, KimA, et al.Total cavopulmonary connection with a new bioabsorbable vascular graft: First clinical experience. J Thorac Cardiovasc Surg, 2017; 153(6):1542–1550.
63.
OderichGS, BowerTC, HoferJ, et al.In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula. J Vasc Surg, 2011; 53(1):99–106, 7.e1–7; discussion 106–7.
NiazOS, RaoA, CareyD, et al.Systematic review and meta: Analysis of aortic graft infections following abdominal aortic aneurysm repair. Int J Vasc Med, 2020; 2020:9574734.
66.
FilibertoAC, ScaliST, PattersonS, et al.Treatment and outcomes of aortic graft infections using a decision algorithm. Ann Vasc Surg, 2021; 76:254–268.
67.
BattM, Jean-BaptisteE, O’ConnorS, et al.; Association Universitaire de Recherche en Chirurgie Vasculaire (AURC). Contemporary management of infrarenal aortic graft infection: Early and late results in 82 patients. Vascular, 2012; 20(3):129–137.
68.
ShuH, WangX, WangM, et al.Surgical management of abdominal aortic graft infection: Network meta-analysis. BJS Open, 2024; 8(1):zrad151.
69.
HeinolaI, KantonenI, JaromaM, et al.Editor’s choice—Treatment of aortic prosthesis infections by graft removal and in situ replacement with autologous femoral veins and fascial strengthening. Eur J Vasc Endovasc Surg, 2016; 51(2):232–239.
70.
Charlton-OuwKM, SandhuHK, HuangG, et al.Reinfection after resection and revascularization of infected infrarenal abdominal aortic grafts. J Vasc Surg, 2014; 59(3):684–692.
71.
GavaliH, ManiK, FurebringM, et al.Editor’s choice - Outcome of radical surgical treatment of abdominal aortic graft and endograft infections comparing extra-anatomic bypass with in situ reconstruction: A nationwide multicentre study. Eur J Vasc Endovasc Surg, 2021; 62(6):918–926.
72.
HustonJM, BariePS, DellingerEP, et al.; Therapeutics and Guidelines Committee. The surgical infection society guidelines on the management of intra-abdominal infection: 2024 update. Surg Infect (Larchmt), 2024; 25(6):419–435.
73.
EvansL, RhodesA, AlhazzaniW, et al.Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med, 2021; 47(11):1181–1247.
74.
SzczotM, MeybeckA, LegoutL, et al.Vascular graft infections in the intensive care unit: Clinical spectrum and prognostic factors. J Infect, 2011; 62(3):204–211.
75.
GarotM, DelannoyPY, MeybeckA, et al.Intra-abdominal aortic graft infection: Prognostic factors associated with in-hospital mortality. BMC Infect Dis, 2014; 14:215.
76.
SmedsMR, DuncanAA, Harlander-LockeMP, et al.; Vascular Low-Frequency Disease Consortium. Treatment and outcomes of aortic endograft infection. J Vasc Surg, 2016; 63(2):332–340.
77.
WuSJ, SunS, TanYH, et al.Analysis of antibiotic strategies to prevent vascular graft or endograft infection after surgical treatment for infective native aortic aneurysms: A systematic review. Antimicrob Resist Infect Control, 2024; 13(1):116.
78.
O’ConnorS, AndrewP, BattM, et al.A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg, 2006; 44(1):38–45.
79.
GotoM, JonesMP, SchweizerML, et al.Association of infectious diseases consultation with long-term postdischarge outcomes among patients with Staphylococcus aureus bacteremia. JAMA Netw Open, 2020; 3(2):e1921048.
